Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients
| Autor: | Araldi, Rodrigo Pinheiro, Prezoto, Benedito Carlos, Gonzaga, Vivian, Policiquio, Bruna, Mendes, Thais Biude, D’Amélio, Fernanda, Vigerelli, Hugo, Viana, Mariana, Valverde, Cristiane Wenceslau, Pagani, Eduardo, Kerkis, Irina |
|---|---|
| Zdroj: | In Biomedicine & Pharmacotherapy May 2022 149 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect